Complement involvement in kidney diseases: From physiopathology to therapeutical targeting
about
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNMonitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension.Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.
P2860
Complement involvement in kidney diseases: From physiopathology to therapeutical targeting
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Complement involvement in kidn ...... ogy to therapeutical targeting
@ast
Complement involvement in kidn ...... ogy to therapeutical targeting
@en
type
label
Complement involvement in kidn ...... ogy to therapeutical targeting
@ast
Complement involvement in kidn ...... ogy to therapeutical targeting
@en
prefLabel
Complement involvement in kidn ...... ogy to therapeutical targeting
@ast
Complement involvement in kidn ...... ogy to therapeutical targeting
@en
P2093
P2860
P356
P1476
Complement involvement in kidn ...... ogy to therapeutical targeting
@en
P2093
Elisabetta Bertoni
Giuseppina Rosso
Maurizio Salvadori
P2860
P304
P356
10.5527/WJN.V4.I2.169
P577
2015-05-01T00:00:00Z